. 2024 Jun 13;25:382. doi: 10.1186/s13063-024-08216-4

Table 1.

Background to clinical trials in which qualitative studies were embedded

Trial identifier	Clinical speciality	Trials arms	Duration of consultation data collection	No. of NHS sites that contributed consultation data
Trial 1 (ISRCTN71502099) [19]	Oncology (brain)	Radiotherapy vs monitoring	31 months	13 (of 20 trials sites)
Trial 2 (ISRCTN86739591) [20]	Oncology (follicular lymphoma)	Guided by results of PET-CT: For patients with a complete metabolic response to induction: standard drug treatment vs monitoring For patients with a partial response to induction: standard drug treatment vs “test” drug plus standard drug treatment	30 months	30 (of 50 trial sites^a)
Trial 3 (ISRCTN14224600) [21]	Oncology (head and neck)	Active laser therapy vs inactive laser therapy	18 months	6 (of 9 trial sites)

Trial identifier

Clinical speciality

Trials arms

Duration of consultation data collection

No. of NHS sites that contributed consultation data

Trial 1 (ISRCTN71502099) [19]

Oncology (brain)

Radiotherapy vs monitoring

31 months

13 (of 20 trials sites)

Trial 2 (ISRCTN86739591) [20]

Oncology (follicular lymphoma)

Guided by results of PET-CT:

For patients with a complete metabolic response to induction:

standard drug treatment vs monitoring

For patients with a partial response to induction:

standard drug treatment vs “test” drug plus standard drug treatment

30 months

30 (of 50 trial sites^a)

Trial 3 (ISRCTN14224600) [21]

Oncology (head and neck)

Active laser therapy vs inactive laser therapy

18 months

6 (of 9 trial sites)

^aAt the time of writing as trial recruitment ongoing. See glossary for further explanation of terms